Product Information

BUPRENORPHINE-NALOXONE 2-0.5 MG SL FILM is a generic product labeled by Ingenus Pharmaceuticals LLC, priced at $1.3326 per EA under NDC 50742039730. Its NADAC has been published 73 times since Jul 2, 2025.

FDA first approved this application on Jun 2, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

BUPRENORPHINE-NALOXONE 2-0.5 MG SL FILM

buprenorphine and naloxone
$1.3326per EA
DEA Schedule CIII

Strength

2; .5 mg/1; mg/1

NDC

50742039730

Classification

Generic

Dosage Form

FILM

Route

BUCCAL; SUBLINGUAL

Effective Date

11/18/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA212756

FDA Approved

6/2/2022

TE Code

AB

On Market Since

8/29/2023

Pharmacological Classes

Opioid Antagonist
Opioid Antagonists
Partial Opioid Agonist
Partial Opioid Agonists

Price Statistics

The NADAC for BUPRENORPHINE-NALOXONE 2-0.5 MG SL FILM has been published 73 times since Jul 2, 2025, and over the history we have for it it has declined 28.4%. The table below summarizes its recorded NADAC range and movement.

Current price$1.3326 per EA
All-time high$1.9156 (Sep 10, 2025)
All-time low$1.2800 (Jun 17, 2026)
52-week high$1.6880
52-week low$1.2800
Median price$1.3854
Average price$1.5206
Largest weekly change-14.4% (Jan 21, 2026)
Weeks tracked73
Tracking sinceJul 2, 2025

Price History

1W

-3.8%

1M

-3.8%

3M

-3.3%

6M

+2.3%

1Y

-21.1%

3Y

N/A

5Y

N/A

All

-28.4%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the buprenorphine and naloxone market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of BUPRENORPHINE-NALOXONE 2-0.5 MG SL FILM?

The current National Average Drug Acquisition Cost (NADAC) for BUPRENORPHINE-NALOXONE 2-0.5 MG SL FILM, manufactured by Ingenus Pharmaceuticals LLC, is $1.3326 per EA (NDC 50742039730), effective Nov 18, 2026.

How has the price of BUPRENORPHINE-NALOXONE 2-0.5 MG SL FILM changed over time?

Over the history we have for it, the NADAC for BUPRENORPHINE-NALOXONE 2-0.5 MG SL FILM has declined 28.4%. It has been tracked across 73 weekly CMS publications since Jul 2, 2025.

What are the highest and lowest recorded NADAC prices for BUPRENORPHINE-NALOXONE 2-0.5 MG SL FILM?

Since Jul 2, 2025, the NADAC for BUPRENORPHINE-NALOXONE 2-0.5 MG SL FILM has ranged from a low of $1.2800 (Jun 17, 2026) to a high of $1.9156 (Sep 10, 2025), with a median of $1.3854 per EA.

Are there cheaper alternatives to BUPRENORPHINE-NALOXONE 2-0.5 MG SL FILM?

No other NADAC-published product currently shares the active ingredient and strength of BUPRENORPHINE-NALOXONE 2-0.5 MG SL FILM in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures BUPRENORPHINE-NALOXONE 2-0.5 MG SL FILM?

BUPRENORPHINE-NALOXONE 2-0.5 MG SL FILM (NDC 50742039730) is labeled by Ingenus Pharmaceuticals LLC, and CMS classifies it as a generic product.